A validated size exclusion chromatography method coupled with fluorescence detection for rapid quantification of bevacizumab in ophthalmic formulations

Bevacizumab is a full-length human monoclonal antibody used to treat various neovascular diseases such as wet age-related macular degeneration (AMD), diabetic eye disease and other problems of the retina. Monthly intravitreal injections of bevacizumab (Avastin®) are effective in the treatment of wet...

Full description

Bibliographic Details
Published in:Journal of Pharmaceutical and Biomedical Analysis
Main Author: Jirjees F.; Soliman K.; Wang Y.; Sonawane R.; Sheshala R.; Jones D.; Thakur R.R.S.
Format: Article
Language:English
Published: Elsevier B.V. 2019
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066322059&doi=10.1016%2fj.jpba.2019.05.038&partnerID=40&md5=d6c196af7aefc5472cc4c5c39e2eff5e

Similar Items